Alyeska Investment Group
BMY icon

Alyeska Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Alyeska Investment Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-329,935
Closed -$20.8M – 728
2021
Q1 		$20.8M Buy
329,935
+106,126
+47% +$6.6M 0.27% 110
2020
Q4 		$13.9M Buy
+223,809
New +$13.8M 0.2% 161
2019
Q1 		– Sell
-320,454
Closed -$16M – 382
2018
Q4 		$16.7M Buy
+320,454
New +$17.2M 0.24% 128
2018
Q2 		– Sell
-998,032
Closed -$63.1M – 460
2018
Q1 		$63.1M Buy
998,032
+407,698
+69% +$26.2M 0.52% 71
2017
Q4 		$36.2M Sell
590,334
-573,008
-49% -$35.8M 0.29% 108
2017
Q3 		$74.2M Sell
1,163,342
-203,037
-15% -$11.9M 0.55% 58
2017
Q2 		$76.1M Sell
1,366,379
-109,045
-7% -$5.93M 0.64% 43
2017
Q1 		$80.2M Buy
+1,475,424
New +$80.9M 0.65% 41
2016
Q4 		– Sell
-347,555
Closed -$18.7M – 479
2016
Q3 		$18.7M Sell
347,555
-557,236
-62% -$35.8M 0.17% 193
2016
Q2 		$66.5M Buy
+904,791
New +$63.9M 0.63% 35
2015
Q3 		– Sell
-581,446
Closed -$38.7M – 472
2015
Q2 		$38.7M Buy
+581,446
New +$38.3M 0.44% 79
2014
Q3 		– Sell
-15,000
Closed -$728K – 389
2014
Q2 		$728K Sell
15,000
-152,362
-91% -$7.51M 0.02% 368
2014
Q1 		$8.69M Sell
167,362
-112,638
-40% -$5.99M 0.24% 154
2013
Q4 		$14.9M Buy
280,000
+5,000
+2% +$255K 0.59% 51
2013
Q3 		$12.7M Buy
275,000
+50,000
+22% +$2.19M 0.52% 66
2013
Q2 		$10.1M Buy
+225,000
New +$9.77M 0.49% 66

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Alyeska Investment Group's BMY Position: Q2 2021 in Review

Alyeska Investment Group sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 329,935 shares — an estimated $20.8M sold.

Alyeska Investment Group first reported a position in BMY in Q2 2013 and held it in 16 quarters. The position peaked at $80.2M in Q1 2017. 2,371 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Alyeska Investment Group reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 329,935 Bristol-Myers Squibb shares in Q2 2021, an estimated $20.8M.
  • Alyeska Investment Group first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 16 quarters.
  • Alyeska Investment Group's Bristol-Myers Squibb position peaked at $80.2M in Q1 2017.
  • 2,371 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.